Activity of propyl p-benzoyloxybenzoate as mu-class glutathione s-transferase inhibitor

Agnes Nora Iska Harnita; Enade Perdana Istyastono; Sudibyo Martono

doi:10.14499/indonesianjpharm0iss0pp76-80

Activity of propyl p-benzoyloxybenzoate as mu-class glutathione s-transferase inhibitor

Agnes Nora Iska Harnita, Enade Perdana Istyastono, Sudibyo Martono

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most prescribed medicines. Anti-inflammatory activity was reported to have relationship with the inhibition of prostaglandin synthesis, one of the inflammation mediators. The inhibition mechanism might be through the cyclooxygenase (COX) inhibition, oxygen radical scavenging, and mu-class glutathione S-transferase (GST) inhibition. Aspirin has been used as a NSAID since a hundred years ago and was reported as cyclooxigenase-1 (COX-1) selective inhibitor. The selectivity leds to gastrointestinal ulceration. Propyl p-benzoyloxybenzoate was a new compound which was predicted to have anti-inflammatory activity and would be developed to be an NSAID with minimum side effect.

mu-class GST inhibition was examined using formation reaction model of GS-CNB conjugate through conjugation of 1,2-dichloro-4-nitrobenzene (DCNB) and glutathione (GSH) with GST (prepared from rat’s liver) as a catalyst. GSTs were isolated from the rat liver cytosolic fraction by centrifugation according to Lundgren. Protein concentration of the cytosol was determined spectrophotometrically by using bovine serum albumin as a standard. The GST activity was determined using conjugation reaction rate between DCNB and GSH, followed by determination of IC50 of propyl p-benzoyloxybenzoate. The result showed that propyl p-benzoyloxybenzoate has activity as mu-class GST inhibitor with IC50 = 111.77 μM as the result from extrapolation.

Key words: Anti-inflammatory, propyl p-benzoyloxybenzoate, inhibitor, mu-class glutathione S-transferase (GST).

Full Text:

Untitled

References

Chandrasekharan, N.V., Dai, H., Roos, K.L.T., Evanson, N.K., Tomsik, J., Elton, T.S., and Simmons, D.L., 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure and expression, PNAS, 99 (21), pp. 13926-13931.

Florensa, N.A., 2003, Sintesis propil p-benzoilbenzoat melalui modifikasi metode Schoten-Baunmann, Skripsi, Fakultas Farmasi, Universitas Sanata Dharma, Yogyakarta.

Habig, W.H., Pabst, M.J., and Jakoby, W.B., 1974, Glutathione S-transferase, The first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249 (22), pp. 7130-7139.

Halliwell, B., Gutterigde, J.M.J., and Arouma, O.S., 1987, The deoksiribosa method : A simple test tube assay for determination of rate constant for reaction of hydroxyl radicals, Anal. Biochem., 165, pp. 215-219.

Lundgren, B., Meijer, J., and DePierre, J.W., 1987, Characterization of the induction of cytosolic and microsomal epoxide hydrolases by 2-ethylhexanoic acid in mouse liver, Drug Metab. Dispos., 15, pp. 114-121.

Roth, G.J, Stanford, N., and Majerus, P.W., 1975, Acetylation of prostaglandin synthetase by aspirin, Proc. Natl. Acad. Sci., 2, pp. 3073-3076.

Sudibyo, M., 2000, Inhibition of glutathione S-transferase by curcumin and its derivatives, Molecular mechanisms and qualitative structure-activity relationships, Dissertation, Gadjah Mada University, Yogyakarta, Indonesia

Supardjan, A. M., 1999, Synthesis and anti-inflammatory activity of Some 4-substitued curcumin derivatives, Dissertation, Gadjah Mada University, Yogyakarta.

Vane, J.R., and Botting, R.M., 1996, Overview-mechanism of action of anti-inflammatory drugs, in Improved Non-Steroid Anti-Inflammatory Drugs COX-2 Enzyme Inhibitors, Edited by Sir John Vane, Dr. Jack Botting and Dr. Regina Botting, pp. 1-28, Kluwer Academic Publishers and William Harvey Press, Great Britain.

Ujihara, M., Tsuchida, S., Satoh, K., Sato, H., and Urade, Y., 1988, Biochemical and immunological demonstration of prostaglandin H2 by various GSTs isoenzymes, Archs. Biochem. Biophys., 264, pp. 428-437.

Wennogle, L.P., Liang., H., and Quintavalla, J.C., 1995, Comparison of recombinant cyclooxygenase-2 to native isoform: Aspirin labelling of the active site, FEBS Lett.,371, pp. 315-320.

DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp76-80